Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction)

  • James Aisenberg
  • , Prapti Chatterjee-Murphy
  • , Kathryn Friedman Flack
  • , Jeffrey I. Weitz
  • , Christian T. Ruff
  • , Francesco Nordio
  • , Michele F. Mercuri
  • , Youngsook Choi
  • , Elliott M. Antman
  • , Eugene Braunwald
  • , Robert P. Giugliano

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction)'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science